Biosynthesis of the major brain gangliosides GD1a and GT1b

Glycobiology

Volumn 22, Issue 10, 2012, Pages 1289-1301

  Sturgill, Elizabeth R ^a   Aoki, Kazuhiro ^b   Lopez, Pablo H H ^a   Colacurcio, Daniel ^a   Vajn, Katarina ^a   Lorenzini, Ileana ^a   Majić, Senka ^a   Yang, Won Ho ^c,d   Heffer, Marija ^e   Tiemeyer, Michael ^b   Marth, Jamey D ^c,d   Schnaar, Ronald L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Molecular Cellular and Developmental Biology   (United States)

^e JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

brain; ganglioside; myelin; sialic acid; sialyltransferase

Indexed keywords

GANGLIOSIDE GD 1A; GANGLIOSIDE GT 1B; SIALIC ACID; SIALYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DEPLETION; GENE; GENE EXPRESSION; HINDLIMB; LIPOGENESIS; MOUSE; NONHUMAN; PATHOLOGICAL REFLEX; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIALYLATION; SIALYLTRANSFERASE3GALACTOSE2 GENE; SIALYLTRANSFERASE3GALACTOSE3 GENE; WILD TYPE;

ANIMALS; BRAIN; GANGLIOSIDES; MICE; MICE, KNOCKOUT; SIALYLTRANSFERASES;

MAMMALIA; MUS;

EID: 84865529249     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws103     Document Type: Article

References (47)

1. Ando S. 1983. Gangliosides in the nervous system. Neurochem Int. 5:507-537. (Pubitemid 13019815)
2. Anumula KR, Taylor PB. 1992. A comprehensive procedure for preparation of partially methylated alditol acetates from glycoprotein carbohydrates. Anal Biochem. 203:101-108.
3. Aoki K, Perlman M, Lim JM, Cantu R, Wells L, Tiemeyer M. 2007. Dynamic developmental elaboration of N-linked glycan complexity in the Drosophila melanogaster embryo. J Biol Chem. 282:9127-9142. (Pubitemid 47093502)
4. Audry M, Jeanneau C, Imberty A, Harduin-Lepers A, Delannoy P, Breton C. 2011. Current trends in the structure-activity relationships of sialyltransferases. Glycobiology. 21:716-726.
5. Boyce S, Webb JK, Carlson E, Rupniak NM, Hill RG, Martin JE. 1999. Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl. Exp Neurol. 155:49-58. (Pubitemid 29072604)
6. Collins BE, Kiso M, Hasegawa A, Tropak MB, Roder JC, Crocker PR, Schnaar RL. 1997. Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem. 272:16889-16895. (Pubitemid 27289788)
7. Collins BE, Yang LJS, Mukhopadhyay G, Filbin MT, Kiso M, Hasegawa A, Schnaar RL. 1997. Sialic acid specificity of myelin-associated glycoprotein binding. J Biol Chem. 272:1248-1255. (Pubitemid 27034624)
8. Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD. 2002. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA. 99:10042-10047. (Pubitemid 34831169)
9. Ellies LG, Sperandio M, Underhill GH, Yousif J, Smith M, Priatel JJ, Kansas GS, Ley K, Marth JD. 2002. Sialyltransferase specificity in selectin ligand formation. Blood. 100:3618-3625. (Pubitemid 35303931)
10. Heffer-Lauc M, Viljetic B, Vajn K, Schnaar RL, Lauc G. 2007. Effects of detergents on the redistribution of gangliosides and GPI-anchored proteins in brain tissue sections. J Histochem Cytochem. 55:805-812. (Pubitemid 47068271)
11. Kawai H, Allende ML, Wada R, Kono M, Sango K, Deng C, Miyakawa T, Crawley JN, Werth N, Bierfreund U, et al. 2001. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem. 276:6885-6888.
12. Kojima N, Lee YC, Hamamoto T, Kurosawa N, Tsuji S. 1994. Kinetic properties and acceptor substrate preferences of two kinds of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain. Biochemistry. 33:5772-5776. (Pubitemid 24184579)
13. Kolter T, Proia RL, Sandhoff K. 2002. Combinatorial ganglioside biosynthesis. J Biol Chem. 277:25859-25862. (Pubitemid 34967063)
14. Kono M, Ohyama Y, Lee YC, Hamamoto T, Kojima N, Tsuji S. 1997. Mouse β-galactoside α2,3-sialyltransferases: Comparison of in vitro substrate specificities and tissue specific expression. Glycobiology. 7:469-479. (Pubitemid 27246720)
15. Kono M, Takashima S, Liu H, Inoue M, Kojima N, Lee YC, Hamamoto T, Tsuji S. 1998. Molecular cloning and functional expression of a fifth-type alpha 2,3-sialyltransferase (mST3Gal V: GM3 synthase). Biochem Biophys Res Commun. 253:170-175. (Pubitemid 29015619)
16. Kracun I, Rosner H, Cosovic C, Stavljenic A. 1984. Topographical atlas of the gangliosides of the adult human brain. J Neurochem. 43:979-989. (Pubitemid 14011251)
17. Lee YC, Kurosawa N, Hamamoto T, Nakaoka T, Tsuji S. 1993. Molecular cloning and expression of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain. Eur J Biochem. 216:377-385. (Pubitemid 23276284)
18. Liu Y, Wada R, Kawai H, Sango K, Deng C, Tai T, McDonald MP, Araujo K, Crawley JN, Bierfreund U, et al. 1999. A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest. 103:497-505. (Pubitemid 29094050)
19. Maccioni HJ, Quiroga R, Ferrari ML. 2011. Cellular and molecular biology of glycosphingolipid glycosylation. J Neurochem. 117:589-602.
20. Nimrichter L, Burdick MM, Aoki K, Laroy W, Fierro MA, Hudson SA, Von Seggern CE, Cotter RJ, Bochner BS, Tiemeyer M, et al. 2008. E-selectin receptors on human leukocytes. Blood. 112:3744-3752.
21. Okajima T, Fukumoto S, Miyazaki H, Ishida H, Kiso M, Furukawa K, Urano T, Furukawa K. 1999. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. J Biol Chem. 274:11479-11486.
22. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL. 2005. Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: Neuropathology and behavioral deficits in single-and double-null mice. Exp Neurol. 195:208-217. (Pubitemid 41116825)
23. Poltorak M, Sadoul R, Keilhauer G, Landa C, Fahrig T, Schachner M. 1987. Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyte-oligodendrocyte interaction. J. Cell Biol. 105:1893-1899.
24. Priatel JJ, Chui D, Hiraoka N, Simmons CJ, Richardson KB, Page DM, Fukuda M, Varki NM, Marth JD. 2000. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity. 12:273-283.
25. Proia RL. 2003. Glycosphingolipid functions: Insights from engineered mouse models. Philos Trans R Soc Lond B Biol Sci. 358:879-883. (Pubitemid 36639712)
26. Rohrer JS. 2000. Analyzing sialic acids using high-performance anion-exchange chromatography with pulsed amperometric detection. Anal Biochem. 283:3-9. (Pubitemid 30469743)
27. Schauer R. 2009. Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol. 19:507-514.
28. Schnaar RL. 1994. Isolation of glycosphingolipids. Methods Enzymol. 230: 348-370. (Pubitemid 24080144)
29. Schnaar RL. 2005. Brain glycolipids: Insights from genetic modifications of biosynthetic enzymes. In: Fukuda M, Rutishauser U, Schnaar RL, Yamaguchi Y, editors. Neuroglycobiology. Oxford (UK): Oxford University Press. p. 95-113.
30. Schnaar RL. 2007. Neural functions of glycolipids. In: Kamerling JP, Boons GJ, Lee YC, Suzuki A, Taniguchi N, Voragen AGJ, editors. Comprehensive Glycoscience. Volume 4: Cell Glycobiology and Development; Health and Disease in Glycomedicine. Amsterdam: Elsevier Science. p. 323-337.
31. Schnaar RL. 2010. Brain gangliosides in axon-myelin stability and axon regeneration. FEBS Lett. 584:1741-1747.
32. Schnaar RL, Fromholt SE, Gong Y, Vyas AA, Laroy W, Wayman DM, Heffer-Lauc M, Ito H, Ishida H, Kiso M, et al. 2002. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem. 302:276-284. (Pubitemid 34229734)
33. Schnaar RL, Lopez PH. 2009. Myelin-associated glycoprotein and its axonal receptors. J Neurosci Res. 87:3267-3276.
34. Schnaar RL, Needham LK. 1994. Thin-layer chromatography of glycosphingolipids. Methods Enzymol. 230:371-389. (Pubitemid 24080145)
35. Sonnino S, Ghidoni R, Chigorno V, Masserini M, Tettamanti G. 1983. Recognition by two-dimensional thin-layer chromatography and densitometric quantification of alkali-labile gangliosides from the brain of different animals. Anal Biochem. 128:104-114. (Pubitemid 13162713)
36. Sun J, Shaper NL, Itonori S, Heffer-Lauc M, Sheikh KA, Schnaar RL. 2004. Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides. Glycobiology. 14:851-857. (Pubitemid 39206887)
37. Svennerholm L. 1964. The gangliosides. J Lipid Res. 5:145-155.
38. Svennerholm L. 1994. Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog Brain Res. 101:xi-xiv.
39. Svennerholm L, Bostrom K, Fredman P, Mansson JE, Rosengren B, Rynmark BM. 1989. Human brain gangliosides: Developmental changes from early fetal stage to advanced age. Biochim Biophys Acta. 1005:109-117. (Pubitemid 19224675)
40. Takamiya K, Yamamoto A, Furukawa K, Yamashiro S, Shin M, Okada M, Fukumoto S, Haraguchi M, Takeda N, Fujimura K, et al. 1996. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci USA. 93:10662-10667. (Pubitemid 26333045)
41. Tettamanti G, Bonali F, Marchesini S, Zambotti V. 1973. A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta. 296:160-170.
42. Todeschini AR, Hakomori SI. 2008. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta. 1780:421-433.
43. Varki A. 1992. Diversity in the sialic acids. Glycobiology. 2:25-40.
44. Vukelic Z, Zamfir AD, Bindila L, Froesch M, Peter-Katalinic J, Usuki S, Yu RK. 2005. Screening and sequencing of complex sialylated and sulfated glycosphingolipid mixtures by negative ion electrospray Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom. 16:571-580. (Pubitemid 40410042)
45. Yamashita T, Hashiramoto A, Haluzik M, Mizukami H, Beck S, Norton A, Kono M, Tsuji S, Daniotti JL, Werth N, et al. 2003. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA. 100:3445-3449. (Pubitemid 36356603)
46. Yang LJS, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL. 1996. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci USA. 93:814-818. (Pubitemid 26041175)
47. Yu RK, Yanagisawa M, Ariga T. 2007. Glycosphingolipid Structures. In: Kamerling JP, Boons GJ, Lee YC, Suzuki A, Taniguchi N, Voragen AGJ, editors. Comprehensive Glycoscience. Volume 1: Introduction to Glycoscience; Synthesis of Carbohydrates. Amsterdam: Elsevier Science. p. 73-122.